Genfit S.A. (EPA:GNFT)
3.355
+0.050 (1.51%)
Apr 1, 2025, 12:31 PM CET
Genfit Revenue
Genfit had revenue of 61.10M EUR in the half year ending June 30, 2024, with 403.23% growth. This brings the company's revenue in the last twelve months to 80.47M, up 175.45% year-over-year. In the year 2023, Genfit had annual revenue of 34.48M with 31.38% growth.
Revenue (ttm)
80.47M
Revenue Growth
+175.45%
P/S Ratio
2.04
Revenue / Employee
476.18K
Employees
159
Market Cap
164.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34.48M | 8.24M | 31.38% |
Dec 31, 2022 | 26.25M | -59.11M | -69.25% |
Dec 31, 2021 | 85.36M | 76.67M | 883.14% |
Dec 31, 2020 | 8.68M | -30.29M | -77.72% |
Dec 31, 2019 | 38.97M | 31.61M | 429.18% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 44.29B |
EssilorLuxottica Société anonyme | 26.51B |
Sartorius Stedim Biotech | 2.78B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.43B |
Genfit News
- 11 days ago - GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders - GlobeNewsWire
- 21 days ago - Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs - GlobeNewsWire
- 4 weeks ago - GENFIT Announces Revenues and Cash Position as of December 31, 2024 - GlobeNewsWire
- 5 weeks ago - Genfit reports preliminary results of repurchase offer to 2025 OCEANEs holders - Seeking Alpha
- 5 weeks ago - GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders' general meeting - GlobeNewsWire
- 6 weeks ago - GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders - GlobeNewsWire
- 7 weeks ago - GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025 - GlobeNewsWire
- 2 months ago - GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan - GlobeNewsWire